Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 00:49:12 - browse：9481

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： FTX founder Sam Bankman

focus

leisure time

WSS

ER docs worry over extreme heat as a 'mass casualty event'

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

The painfully weak evidence on taking collagen to treat arthritis

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

In venture capital firm's success, lessons for turning crisis into profit

US soldier in North Korean custody after crossing DMZ line

focus

Wikipedia

hotspot

Cancer drug shortages should be causing more outrage

US soldier in North Korean custody after crossing DMZ line

Moonlake's readout produced a cash windfall. Risks remain

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Sports medicine is finally prioritizing gender equality

FTX founder Sam Bankman

Medicare details structure of new drug price negotiation program

Why you get paid to donate plasma but not blood

BioMarin wins approval for gene therapy to treat hemophilia A

More regulation could be coming for drug ads

hotspot

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Ohioans vote in high

Choosing scientific sides in the fight against Alzheimer's

Twill hunts for pharma partner to market its depression app

CDC launches VaccineFinder tool to locate Covid

Ford plant in Missouri shuts down over 'possible threat,' sheriff's office says

explore

focus

leisure time

hotspot